Both in Pharmaceuticals
Enliven Therapeutics vs Amylyx Pharmaceuticals
Over the past year ELVN returned +123.2% and AMLX returned +106.2%; their daily moves had a correlation of 0.24.
ELVN +123.2% AMLX +106.2%Growth of $1, one year, split-adjusted
| Metric | ELVN | AMLX |
|---|---|---|
| Price | $44.63 | $28.04 |
| Market cap | $3.27B | $3.52B |
| Today | +0.86% | −2.84% |
| 1 month | −5.0% | +0.9% |
| 6 months | +7.3% | +70.4% |
| Year to date | +189.8% | +132.1% |
| 1 year | +86.2% | +99.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $895.2M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 40.1% | 112.2% |
| Short % of float | 16.4% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).